AXIN2 and hepatocellular carcinoma: In hepatoma cells, inhibition of Axin2 expression causes the abnormal activation of the Wnt/β-catenin signaling pathway and promotes the abnormal expression of transcription activator STAT3, which promotes the occurrence of tumors, revealing that Axin2 gene expression may be involved in the regulation of hepatocarcinogenesis [18].